Display options
Share it on

Nanomaterials (Basel). 2020 Jun 21;10(6). doi: 10.3390/nano10061211.

Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein.

Nanomaterials (Basel, Switzerland)

Rossella De Marco, Enrico Rampazzo, Junwei Zhao, Luca Prodi, Mayra Paolillo, Pierre Picchetti, Francesca Gallo, Natalia Calonghi, Luca Gentilucci

Affiliations

  1. Department of Agricultural, Food, Enviromental and Animal Sciences (DI4A), University of Udine, 33100 Udine, Italy.
  2. Department of Chemistry "G. Ciamician", University of Bologna, 40126 Bologna, Italy.
  3. Department of Drugs Sciences, University of Pavia, 27100 Pavia, Italy.
  4. Institut de Science et d'Ingénierie Supramoléculaires (ISIS), Université de Strasbourg, 67083 Strasbourg, France.
  5. Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.

PMID: 32575872 PMCID: PMC7353088 DOI: 10.3390/nano10061211

Abstract

Cancer cells demonstrate elevated expression levels of the inhibitor of apoptosis proteins (IAPs), contributing to tumor cell survival, disease progression, chemo-resistance, and poor prognosis. Smac/DIABLO is a mitochondrial protein that promotes apoptosis by neutralizing members of the IAP family. Herein, we describe the preparation and in vitro validation of a synthetic mimic of Smac/DIABLO, based on fluorescent polyethylene glycol (PEG)-coated silica-core nanoparticles (NPs) carrying a Smac/DIABLO-derived pro-apoptotic peptide and a tumor-homing integrin peptide ligand. At low μM concentration, the NPs showed significant toxicity towards A549, U373, and HeLa cancer cells and modest toxicity towards other integrin-expressing cells, correlated with integrin-mediated cell uptake and consequent highly increased levels of apoptotic activity, without perturbing cells not expressing the α5 integrin subunit.

Keywords: AVPI; IAP; RGD; Smac/DIABLO; cancer; cellular uptake; confocal microscopy; drug delivery; silica nanoparticles

References

  1. Apoptosis. 2017 Jul;22(7):898-919 - PubMed
  2. Photochem Photobiol Sci. 2016 Nov 2;15(11):1400-1407 - PubMed
  3. Org Biomol Chem. 2014 May 28;12(20):3288-302 - PubMed
  4. ACS Appl Mater Interfaces. 2015 Apr 22;7(15):8005-12 - PubMed
  5. Nano Converg. 2018 Dec 12;5(1):38 - PubMed
  6. Int J Cancer. 1998 Mar 30;76(1):91-8 - PubMed
  7. Exp Cell Res. 1997 Jul 10;234(1):156-64 - PubMed
  8. Bioorg Med Chem Lett. 2014 May 15;24(10):2374-8 - PubMed
  9. Future Med Chem. 2017 Apr;9(6):579-604 - PubMed
  10. Cancers (Basel). 2017 Sep 04;9(9): - PubMed
  11. ACS Nano. 2013 Oct 22;7(10):8645-57 - PubMed
  12. Angew Chem Int Ed Engl. 2011 Apr 26;50(18):4056-66 - PubMed
  13. Chemistry. 2014 Oct 6;20(41):13390-404 - PubMed
  14. J Am Chem Soc. 2006 May 17;128(19):6447-53 - PubMed
  15. Chemistry. 2018 Nov 13;24(63):16743-16746 - PubMed
  16. Artif Cells Nanomed Biotechnol. 2018;46(sup2):295-305 - PubMed
  17. J Phys Chem B. 2010 Nov 18;114(45):14605-13 - PubMed
  18. Nature. 2000 Dec 21-28;408(6815):1008-12 - PubMed
  19. Curr Pharm Des. 2010;16(28):3185-203 - PubMed
  20. ChemistryOpen. 2019 Jun 07;8(6):737-742 - PubMed
  21. Biomaterials. 2013 Oct;34(31):7744-53 - PubMed
  22. Bioorg Med Chem Lett. 2014 Aug 1;24(15):3361-5 - PubMed
  23. Cell. 2000 Jul 7;102(1):33-42 - PubMed
  24. Curr Med Chem. 2006;13(20):2449-66 - PubMed
  25. Recent Pat Anticancer Drug Discov. 2017;12(2):148-168 - PubMed
  26. Adv Drug Deliv Rev. 2017 Sep 15;119:101-119 - PubMed
  27. Comput Struct Biotechnol J. 2019 Jan 25;17:142-150 - PubMed
  28. Angew Chem Int Ed Engl. 2016 Jun 13;55(25):7048-67 - PubMed
  29. Chem Soc Rev. 2018 May 21;47(10):3574-3620 - PubMed
  30. Bioconjug Chem. 2015 Sep 16;26(9):1873-8 - PubMed
  31. Chem Commun (Camb). 2012 May 4;48(35):4187-9 - PubMed
  32. Annu Rev Med. 2012;63:185-98 - PubMed
  33. Langmuir. 2013 Apr 2;29(13):4350-6 - PubMed
  34. Nat Rev Cancer. 2010 Jan;10(1):9-22 - PubMed
  35. Nanoscale. 2012 Feb 7;4(3):824-30 - PubMed
  36. J Fluoresc. 2005 Sep;15(5):679-88 - PubMed
  37. Peptides. 2009 Dec;30(12):2374-9 - PubMed
  38. FEBS J. 2016 Jan;283(2):221-31 - PubMed
  39. Bioconjug Chem. 2017 Sep 20;28(9):2241-2245 - PubMed
  40. Cells. 2013 Mar 14;2(1):163-87 - PubMed
  41. J Virol. 1993 Apr;67(4):2168-74 - PubMed
  42. Front Microbiol. 2018 Nov 06;9:2630 - PubMed
  43. J Biotechnol. 2004 Aug 26;112(1-2):73-7 - PubMed
  44. Cell Death Differ. 2008 May;15(5):920-8 - PubMed
  45. Cancer Res. 2003 Feb 15;63(4):831-7 - PubMed
  46. Biopolymers. 2017 Nov 27;: - PubMed
  47. Apoptosis. 2017 Dec;22(12):1487-1509 - PubMed
  48. Bioorg Med Chem Lett. 2013 Jul 15;23(14):4253-7 - PubMed
  49. Nature. 1997 Jul 17;388(6639):300-4 - PubMed

Publication Types

Grant support